Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

71.24
-0.6100-0.85%
Post-market: 71.240.00000.00%18:03 EDT
Volume:907.29K
Turnover:65.06M
Market Cap:7.55B
PE:62.36
High:73.13
Open:72.04
Low:70.78
Close:71.85
Loading ...

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag

Zacks
·
02 Apr

CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal

Zacks
·
01 Apr

Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
01 Apr

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

Zacks
·
01 Apr

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

Zacks
·
01 Apr

Why Corcept Therapeutics Incorporated (CORT) Went Up On Monday?

Insider Monkey
·
01 Apr

Canaccord Genuity Sticks to Its Buy Rating for Corcept Therapeutics (CORT)

TIPRANKS
·
01 Apr

Corcept Therapeutics Inc : Piper Sandler Raises Target Price to $128 From $78

THOMSON REUTERS
·
01 Apr

Small U.S. Stocks End Mixed As Corcept Therapeutics Lead, LZ Technology Holdings Lags

Dow Jones
·
01 Apr

Equity Markets Mixed Ahead of Tariff Announcements

MT Newswires Live
·
01 Apr

Why Is Corcept (CORT) Stock Soaring Today

StockStory
·
01 Apr

Corcept Therapeutics (NasdaqCM:CORT) Reports Positive Phase 3 Results Despite 8% Share Price Dip

Simply Wall St.
·
01 Apr

Top Midday Gainers

MT Newswires Live
·
01 Apr

Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
01 Apr

Piper Sandler Raises Corcept Therapeutics' Price Target to $128 From $78, Maintains Overweight Rating

MT Newswires Live
·
31 Mar

Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet

Benzinga
·
31 Mar

Corcept Therapeutics price target raised to $128 from $78 at Piper Sandler

TIPRANKS
·
31 Mar

Truist Securities Adjusts Corcept Therapeutics Price Target to $150 From $76, Maintains Buy Rating

MT Newswires Live
·
31 Mar

BUZZ-Corcept hits record high as ovarian cancer drug succeeds late-stage trial

Reuters
·
31 Mar

Corcept Therapeutics Inc : Truist Securities Raises Target Price to $150 From $76

THOMSON REUTERS
·
31 Mar